Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: clonidine hydrochloride

Summary for Generic Name: clonidine hydrochloride

Drug Master File Entries: see list20
Suppliers: see list4
Therapeutic Class:Cardiovascular Agents

Pharmacology for Ingredient: clonidine hydrochloride

Clinical Trials for: clonidine hydrochloride

Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum
Status: Completed Condition: Hyperemesis Gravidarum

Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers
Status: Completed Condition: Healthy

Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia
Status: Not yet recruiting Condition: Encephalopathy, Hypoxic-Ischemic

Effect of Intrathecal Clonidine in Hypertensive Subjects With Poorly Controlled Blood Pressure
Status: Completed Condition: Hypertension

The Effect of Clonidine-enhanced Sedation on Delirium in Ventilated Critically Ill Patients
Status: Not yet recruiting Condition: Delirium

Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain
Status: Not yet recruiting Condition: Labor Pain

Epidural Clonidine for Lumbosacral Radiculopathy
Status: Terminated Condition: Lumbar and Other Intervertebral Disc Disorders With Radiculopathy

Comparison of Different Doses of Clonidine to Fentanyl as an Adjuvant to Bupivacaine 0.5% for Spinal Anesthesia
Status: Withdrawn Condition: Full Term Pregnant Patients; Undergoing Lower Segment Caesarian Section

Clonidine Versus Adenosine to Treat Neuropathic Pain
Status: Completed Condition: Pain

Efficacy & Safety of KAPVAYâ„¢ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Status: Completed Condition: Attention Deficit Hyperactivity Disorder

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Exela Pharma Scs Llc
clonidine hydrochloride
INJECTABLE;INJECTION203167Oct 29, 2013RXNo<disabled>
Fresenius Kabi Usa
clonidine hydrochloride
INJECTABLE;INJECTION200673Jul 8, 2011RXNo<disabled>
Hikma Farmaceutica
clonidine hydrochloride
INJECTABLE;INJECTION200300Jan 26, 2011RXNo<disabled>
clonidine hydrochloride
INJECTABLE;INJECTION091104Oct 8, 2009RXNo<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology